These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30388032)

  • 1. Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children.
    Childress AC; Stark JG
    J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):606-614. PubMed ID: 30388032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practitioner Review: Assessment and treatment of preschool children with attention-deficit/hyperactivity disorder.
    Halperin JM; Marks DJ
    J Child Psychol Psychiatry; 2019 Sep; 60(9):930-943. PubMed ID: 30690737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder.
    Kratochvil CJ; Greenhill LL; March JS; Burke WJ; Vaughan BS
    CNS Drugs; 2004; 18(14):957-66. PubMed ID: 15584766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder in preschool children.
    Greenhill LL; Posner K; Vaughan BS; Kratochvil CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):347-66, ix. PubMed ID: 18295150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care.
    Goodman DW; Mitchell S; Rhodewalt L; Surman CB
    Drugs Aging; 2016 Jan; 33(1):27-36. PubMed ID: 26659731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychomotor development and learning difficulties in preschool children with probable attention deficit hyperactivity disorder: An epidemiological study in Navarre and La Rioja.
    Marín-Méndez JJ; Borra-Ruiz MC; Álvarez-Gómez MJ; Soutullo Esperón C
    Neurologia; 2017 Oct; 32(8):487-493. PubMed ID: 27091681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder.
    Wigal SB; Wigal TL
    CNS Spectr; 2007 Jun; 12(6 Suppl 9):1-14; quiz 15-6. PubMed ID: 17545959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background, clinical features and treatment of attention deficit hyperactivity disorder in children.
    Warikoo N; Faraone SV
    Expert Opin Pharmacother; 2013 Oct; 14(14):1885-906. PubMed ID: 23865438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of probable Attention-Deficit/Hyperactivity Disorder symptoms: result from a Spanish sample of children.
    Cerrillo-Urbina AJ; García-Hermoso A; Martínez-Vizcaíno V; Pardo-Guijarro MJ; Ruiz-Hermosa A; Sánchez-López M
    BMC Pediatr; 2018 Mar; 18(1):111. PubMed ID: 29544457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention deficit hyperactivity disorder: comorbidity and medication use.
    Kube DA; Petersen MC; Palmer FB
    Clin Pediatr (Phila); 2002 Sep; 41(7):461-9. PubMed ID: 12365307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early developmental cues for diagnosis of attention deficit/hyperactivity disorder in young children.
    Berger I; Nevo Y
    Dev Disabil Res Rev; 2011; 17(2):170-9. PubMed ID: 23362036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects.
    Golmirzaei J; Mahboobi H; Yazdanparast M; Mushtaq G; Kamal MA; Hamzei E
    Curr Pharm Des; 2016; 22(5):590-4. PubMed ID: 26601963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
    Crippa A; Tesei A; Sangiorgio F; Salandi A; Trabattoni S; Grazioli S; Agostoni C; Molteni M; Nobile M
    Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):571-583. PubMed ID: 30246216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.